Prescription Drugs Academy Health 6/24/18 Figure 1 NASEM Committee - - PowerPoint PPT Presentation

▶
prescription drugs
SMART_READER_LITE
LIVE PREVIEW

Prescription Drugs Academy Health 6/24/18 Figure 1 NASEM Committee - - PowerPoint PPT Presentation

Jan 16, 2023 113 likes •188 views

Ensuring Access to Affordable Prescription Drugs Academy Health 6/24/18 Figure 1 NASEM Committee Members Norman Augustine (Chair), Former, Eliseo Prez-Stable, National Institutes of Lockheed Martin Corporation Health

slide-1
SLIDE 1

Ensuring Access to Affordable Prescription Drugs

Academy Health 6/24/18

slide-2
SLIDE 2

Figure 1

  • Norman Augustine (Chair), Former,

Lockheed Martin Corporation

  • Jeff Bingaman, Former U.S. Senator, NM
  • Rena Conti, University of Chicago
  • Stacie Dusetzina, University of North

Carolina

  • Martha Gaines, University of Wisconsin Law

School

  • Rebekah Gee, LA Department of Health
  • Victoria Hale, Oneworld Health and

Medicines360

  • Michelle Mello, Stanford Law School
  • Eliseo Pérez-Stable, National Institutes of

Health

  • Charles Phelps, University of Rochester
  • Michael Rosenblatt, Flagship Pioneering
  • Diane Rowland, Kaiser Family Foundation
  • Vinod Sahney, Northeastern University
  • Peter Sands, Harvard Kennedy School and

Harvard Global Health Institute

  • *Henri Termeer, Former, Genzyme Corporation
  • Reed Tuckson, Tuckson Health Connections
  • Alan Weil, Health Affairs and Project Hope

NASEM Committee Members

slide-3
SLIDE 3

Figure 2

  • Examine patient access to affordable and effective therapies

with emphasis on drug pricing, inflation in the cost of drugs, and insurance design

  • Structural factors influencing drug pricing
  • Policy factors related to insurance design and state

prescribing laws

  • Role of drug access programs and 340B
  • Role of comparative effectiveness assessments
  • How to prevent drug shortage and foster innovation

Statement of Task

slide-4
SLIDE 4

Figure 3

Over half of Americans report currently taking at least one prescription medicine

SOURCE: KFF Health Tracking Poll (conducted March 8-13, 2018)

12% 11% 9% 25%

1 in 4 Americans say they take four or more prescription drugs

+

No t …

58%

slide-5
SLIDE 5

Figure 4

  • Improving patient access to effective and affordable

medicines is a national imperative not being adequately served by biopharmaceutical sector today.

  • Report’s major recommendations offer a path forward

with associated implementation steps.

Making Medicines Affordable Conclusion

slide-6
SLIDE 6

Figure 5

RECOMMENDATIONS

GENERICS, BIOSIMILARS & ORPHAN DRUGS CHANGING BENEFIT DESIGN FINANCIAL TRANSPARENCY IN PRICING LEVERAGING PURCHASING POWER